Date |
Symbol |
Description |
Type |
Disease |
Designation |
Success Rating |
H2 2016
|
ALKS |
|
sNDA Submission |
Other |
None |
|
H2 2016
|
ARRY |
|
Phase 3 Results |
Oncology |
Orphan Drug |
|
H2 2016
|
CHRS |
|
Phase 3 Results |
Other |
None |
|
H2 2016
|
CRMD |
|
Phase 3 Results |
Other |
Fast Track |
|
Q4 2016
|
GWPH |
|
NDA Submission |
Neurology |
Fast Track, Orphan Drug |
|
H2 2016
|
HZNP |
|
Phase 3 Results |
Neurology |
Fast Track, Orphan Drug |
|
Q4 2016
|
ITEK |
|
Phase 3 Results |
Opthamology |
None |
|
H2 2016
|
LXRX |
|
Phase 3 Results |
Endocrine |
None |
|
H2 2016
|
BOTA |
|
Phase 2b Results |
Infectious Disease |
None |
|
Q4 2016
|
CATB |
|
Phase 2 Results |
Other |
Orphan Drug |
|